MYLS22
Product Specifications
CAS Number
306959-01-3
Target
Others
Related Pathways
Others
Purity
0.9977
Bioactivity
MYLS22 is a first-in-class and selective inhibitor of optic atrophy 1 (OPA1) . MYLS22 can target endothelial OPA1 to curtail tumor growth and inhibits angiogenesis by impinging on NFkB activity and on angiogenic gene expression. It with anti-angiogenesis and anti-cancer activity.
Smiles
Cc1nn(-c2ccccc2)c2sc(cc12)C(=O)Nc1c(C)n(C)n(-c2ccccc2)c1=O
Molecular Formula
C24H21N5O2S
Molecular Weight
443.52
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
abx325689-01 50 µg
CUB Domain Containing Protein 1 (CDCP1) Antibody
Sign In for Pricing
View Details abx325689-02 100 µg
CUB Domain Containing Protein 1 (CDCP1) Antibody
Sign In for Pricing
View Details NBP2-09806 0.1 mg
TROVE2 Overexpression Lysate (Native) - (Dry Ice)
Sign In for Pricing
View Details rAP-4437 1 Each
DNA Fragmentation Factor Subunit Alpha Human Recombinant
Sign In for Pricing
View Details 
NSL0103Ca 96 Tests
Canine Breast Cancer Susceptibility Protein 1 (BRCA1) ELISA Kit
Sign In for Pricing
View Details